Andrew Wilber

4.0k citations
62 papers · 2.8k indexed · h-index 28
  • Oncology top 5%
    • Lymphatic System and Diseases 6
    • Cancer Cells and Metastasis 6
    • CAR-T cell therapy research 5
  • Genetics top 5%
    • Virus-based gene therapy research 16
    • Animal Genetics and Reproduction 9
    • Hemoglobinopathies and Related Disorders 6
    • RNA Interference and Gene Delivery 14
    • CRISPR and Genetic Engineering 8
  • Genetics top 5%
    • Virus-based gene therapy research 16
    • Animal Genetics and Reproduction 9
    • Hemoglobinopathies and Related Disorders 6

Andrew Wilber

62 papers receiving 2.7k citations

Peers

Andrew Wilber
Comparison fields: 5 of 113
  • Oncology 895
  • Genetics 308
  • Molecular Biology 1.7k
  • Cancer Research 353
  • Genetics 556
Replace Andreas Gast with:
Andreas Gast Germany
Gaetano Romano United States
Hesed Padilla‐Nash United States
Catherine I. Dumur United States
Perry D. Nisen United States
Steven Goossens Belgium
Adam J. Dupuy United States
Jesús Pérez‐Losada Spain
Annalisa Frattini Italy
Kenkichi Masutomi Japan
Andrew Wilber relative to Andreas Gast Germany Andreas Gast's profile →
Citations per field
00.5×
Andreas Gast · 1×
Citations per year

Countries citing papers authored by Andrew Wilber

Since Specialization
Citations

This map shows the geographic impact of Andrew Wilber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Wilber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Wilber more than expected).

Fields of papers citing papers by Andrew Wilber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Wilber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Wilber. The network helps show where Andrew Wilber may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew Wilber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Wilber Line = papers co-authored together Andrew Wilber links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20253
2 202223
3 20211
4 20201
5 202016
6 201846
7 201621
8 20165
9 201528
10 20155
11 2013146
12 201230
13 201211
14 2011160
15 201125
16 200929
17 200919
18 200847
19 2006260
20 200553

About Andrew Wilber

Andrew Wilber is a scholar working on Genetics, Oncology and Genetics, having authored 62 papers that have together received 2.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (16 papers), RNA Interference and Gene Delivery (14 papers), Animal Genetics and Reproduction (9 papers), CRISPR and Genetic Engineering (8 papers), Lymphatic System and Diseases (6 papers), Cancer Cells and Metastasis (6 papers), Hemoglobinopathies and Related Disorders (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (895 citations), Genetics (308 citations) and Molecular Biology (1.7k citations). Andrew Wilber has collaborated with scholars based in United States, Japan and China. Frequent co-authors include R. Scott McIvor, Derek A. Persons, Arthur W. Nienhuis, David A. Largaespada, Perry B. Hackett, Christopher B. Chambers, Aya Kobayashi, Kounosuke Watabe, Puspa R. Pandey and Misako Watabe. Their work appears in journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026